Other functions - maintenance services for fluidigm biomark real time PCR reader, (2) IFC controller AX and IFC controller MX

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600504P
Awardee
Awarding agency
Obligated
$76,640

Award facts

Opportunity
Contract value 100% obligated
$76,640.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 · DE-obligation of funds from FY2016 expiring lines. -$0
Exercise an Option P00003 $19,160
Exercise an Option 2 $19,160
Exercise an Option 1 $19,160
Original award $19,160

About this award

The National Cancer Institute awarded a purchase order to The Remi Group LLC on July 28, 2016, valued at $76,640.28 for maintenance services on Fluidigm Biomark real-time PCR reader and IFC Controller AX and MX equipment. Work is performed in Bethesda, Maryland, with an ultimate completion date of June 2, 2021. The order was funded through de-obligation of expiring FY2016 lines and carries firm fixed-price pricing under full and open competition.

Quick answers

Who was awarded contract HHSN261201600504P?

HHSN261201600504P was awarded to The Remi Group LLC by National Cancer Institute (National Institutes of Health) on July 28, 2016.

How much is contract HHSN261201600504P worth?

The government has obligated $76,640 on HHSN261201600504P.

Was contract HHSN261201600504P competed?

The extent of competition for HHSN261201600504P was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award